論文 - 佐藤 光夫
-
Pseudomembranous Invasive Tracheobronchial Aspergillosis with Fulminant Hepatitis and Hemophagocytic Syndrome. 査読有り
Majima S, Okachi S, Asano M, Wakahara K, Hashimoto N, Sato M, Ishigami M, Hasegawa Y.
Intern Med. 57 巻 頁： 2371-2375 2018年8月
-
eIF2β, a Subunit of Translation-Initiation Factor EIF2, Is a Potential Therapeutic Target for Non-Small Cell Lung Cancer.
Tanaka I, Sato M (corresponding author), Kato T, Goto D, Kakumu T, Miyazawa A, Yogo N, Hase T, Morise M, Sekido Y, Girard L, Minna JD, Byers LA, Heymach JV, Coombes KR, Kondo M, Hasegawa Y.
Cancer Sci. 頁： 10.1111/cas.13602. 2018年4月
-
Safety and efficacy of diagnostic flexible bronchoscopy in very old patients with lung cancer 査読有り
Shotaro Okachi, Kazuyoshi Imaizumi, Naoyuki Imai, Takahiro Shimizu, Tetsunari Hase, Masahiro Morise, Naozumi Hashimoto, Mitsuo Sato, Yoshinori Hasegawa
European Geriatric Medicine 9 巻 頁： 255-262 2018年2月
-
Lung Metastases from Bile Duct Adenocarcinoma Mimicking Chronic Airway Infection and Causing Diagnostic Difficulty.
Sato M, Okachi S, Fukihara J, Shimoyama Y, Wakahara K, Sakakibara T, Hase T, Onishi Y, Ogura Y, Maeda O, Hasegawa Y.
Intern Med. 頁： 10.2169/internalmedicine.9718-17. 2017年12月
-
Regulation of PD-L1 expression by matrix stiffness in lung cancer cells. 査読有り
Miyazawa A, Ito S, Asano S, Tanaka I, Sato M, Kondo M, Hasegawa Y
Biochemical and biophysical research communications 2017年12月
-
Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer. 査読有り
Kakumu T, Sato M (corresponding author), Goto D, Kato T, Yogo N, Hase T, Morise M, Fukui T, Yokoi K, Sekido Y, Girard L, Minna JD, Byers LA, Heymach JV6, Coombes KR, Kondo M, Hasegawa Y
Cancer Sci. 108 巻 頁： 732-743 2017年4月
-
ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. 査読有り
Larsen JE, Nathan V, Osborne JK, Farrow RK, Deb D, Sullivan JP, Dospoy PD, Augustyn A, Hight SK, Sato M, Girard L, Behrens C, Wistuba II, Gazdar AF, Hayward NK, Minna JD.
J Clin Invest. 2016年8月
-
Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis. 査読有り
10 巻 頁： e0134842 2015年8月
-
Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells. 査読有り
Yamashita R, Sato M, Kakumu T, Hase T, Yogo N, Maruyama E, Sekido Y, Kondo M, Hasegawa Y.
Cancer Med. 4 巻 頁： 551-564 2015年4月
-
Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations. 査読有り
Sato M, Larsen JE, Lee W, Sun H, Shames DS, Dalvi MP, Ramirez RD, Tang H, Dimaio JM, Gao B, Xie Y, Wistuba II, Gazdar AF, Shay JW, Minna JD.
頁： Epub ahead of print 2013年
-
Primary prophylaxis indication for docetaxel induced febrile neutropenia in elderly patients with non-small cell lung cancer
Akira Matsui;Masahiro Morise;Ichidai Tanaka;Sachiko Ozone;Reiko Matsuzawa;Junji Koyama;Tetsunari Hase;Naozumi Hashimoto;Mitsuo Sato;Yoshinori Hasegawa
Cancer Investigation In press 巻 ( In press ) 頁： 1-19 2020年8月
-
Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing. 査読有り
Mizugaki H, Hamada A, Shibata T, Hosoda F, Nakamura H, Okuma Y, Shukuya T, Umemura S, Horiike A, Fukui T, Kogure Y, Daga H, Urata Y, Yamada K, Saeki S, Fujisaka Y, Nakamura Y, Sato M, Yoshida T, Hotta T, Oizumi S, Fujiwara Y, Ohe Y, Fujiwara Y.
Lung Cancer. 128 巻 頁： 20-25 2018年12月
-
NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM. 査読有り
Osborne JK, Larsen JE, Shields MD, Gonzales JX, Shames DS, Sato M, Kulkarni A, Wistuba II, Girard L, Minna JD, Cobb MH.
Proc Natl Acad Sci U S A. 110 巻 ( 16 ) 頁： 6524-9 2013年
-
(Review article) Emerging evidence of Epithelial-to-Mesenchymal Transition in lung carcinogenesis. 招待有り 査読有り
Sato M, Shames DS, Hasegawa Y.
Respirology. 2012年
-
Nongenomic effects of fluticasone propionate and budesonide on human airway anion secretion. 査読有り
Mizutani T, Morise M, Ito Y, Hibino Y, Matsuno T, Ito S, Hashimoto N, Sato M, Kondo M, Imaizumi K, Hasegawa Y.
Am J Respir Cell Mol Biol 47 巻 頁： 645 2012年
-
Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer. 査読有り
Sunaga N, Kaira K, Imai H, Shimizu K, Nakano T, Shames DS, Girard L, Soh J, Sato M, Iwasaki Y, Ishizuka T, Gazdar AF, Minna JD, Mori M.
Oncogene. 頁： 10.1038/onc 2012年
-
NeuroD1 regulation of migration accompanies the differential sensitivity of neuroendocrine carcinomas to TrkB inhibition. 査読有り
Osborne JK, Larsen JE, Gonzales JX, Shames DS, Sato M, Wistuba II, Girard L, Minna JD, Cobb MH.
Oncogenesis 2013年
-
The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma. 査読有り
Elshazley M, Sato M, Hase T, Yamashita R, Yoshida K, Toyokuni S, Ishiguro F, Osada H, Sekido Y, Yokoi K, Usami N, Shames DS, Kondo M, Gazdar AF, Minna JD, Hasegawa Y.
Int J Cancer. 2012年
-
Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer. 査読有り
Sunaga N, Imai H, Shimizu K, Shames DS, Kakegawa S, Girard L, Sato M, Kaira K, Ishizuka T, Gazdar AF, Minna JD, Mori M.
Int J Cancer. 130 巻 頁： 1733 2012年
-
STIM1 regulates platelet-derived growth factor-induced migration and Ca2+ influx in human airway smooth muscle cells. 査読有り
Suganuma N, Ito S, Aso H, Kondo M, Sato M, Sokabe M, Hasegawa Y.
PLoS One 7 巻 頁： e45056 2012年